Overseas studies under increasing scrutiny

12/1/2008 | Wall Street Journal, The

Western drugmakers and regulators are under mounting pressure to ensure the safety of clinical trials conducted in developing countries after reports of death and complications in participants. Some experts are concerned about possible violations of clinical-testing rules, while others worry that companies may be taking advantage of individuals desperate to join studies. Drugmakers said they follow the rules when conducting trials abroad, including securing government authorization and routinely inspecting sites.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC